John Fung to Mice, Inbred C3H
This is a "connection" page, showing publications John Fung has written about Mice, Inbred C3H.
Connection Strength
0.761
-
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
Score: 0.036
-
Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1168-9.
Score: 0.035
-
Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
Score: 0.034
-
Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc. 1995 Feb; 27(1):509-10.
Score: 0.031
-
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc. 1995 Feb; 27(1):511-2.
Score: 0.031
-
Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol. 2009 Sep; 51(3):510-9.
Score: 0.021
-
Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells. Transplant Proc. 2007 Jan-Feb; 39(1):281-2.
Score: 0.018
-
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg. 2005 Mar; 241(3):497-505.
Score: 0.015
-
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
Score: 0.015
-
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. Transplant Proc. 2004 Jun; 36(5):1592-4.
Score: 0.015
-
Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol. 2004 Feb 01; 172(3):1355-63.
Score: 0.014
-
Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
Score: 0.014
-
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes. 2003 Aug; 52(8):1976-85.
Score: 0.014
-
Prolonged survival of heart allografts transduced with AAV-CTLA4Ig. Microsurgery. 2003; 23(5):489-93.
Score: 0.013
-
Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
Score: 0.013
-
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
Score: 0.013
-
Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function. Transplant Proc. 2002 Aug; 34(5):1394-5.
Score: 0.013
-
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
Score: 0.012
-
Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
Score: 0.012
-
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):129-30.
Score: 0.012
-
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
Score: 0.012
-
Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of posttransplant vasculopathy: salutary effects of perioperative costimulatory blockade. Transplant Proc. 2001 Feb-Mar; 33(1-2):307.
Score: 0.012
-
Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation. Transplant Proc. 2001 Feb-Mar; 33(1-2):382.
Score: 0.012
-
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. Transplant Proc. 2001 Feb-Mar; 33(1-2):525.
Score: 0.012
-
Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):604.
Score: 0.012
-
Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
Score: 0.012
-
Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology. 2000 Oct; 101(2):233-41.
Score: 0.011
-
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
Score: 0.011
-
Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
Score: 0.011
-
Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation. 1999 May 27; 67(10):1295-300.
Score: 0.010
-
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Transplantation. 1999 Feb 15; 67(3):444-50.
Score: 0.010
-
Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses. Transplant Proc. 1999 Feb-Mar; 31(1-2):115.
Score: 0.010
-
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
Score: 0.010
-
Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant Proc. 1999 Feb-Mar; 31(1-2):784.
Score: 0.010
-
Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
Score: 0.010
-
Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface. Transplant Proc. 1999 Feb-Mar; 31(1-2):845.
Score: 0.010
-
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc. 1999 Feb-Mar; 31(1-2):1195.
Score: 0.010
-
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
Score: 0.010
-
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
Score: 0.010
-
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
Score: 0.010
-
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
Score: 0.010
-
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc. 1998 Jun; 30(4):941-2.
Score: 0.010
-
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
Score: 0.009
-
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
Score: 0.009
-
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
Score: 0.009
-
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997 May 15; 158(10):4654-61.
Score: 0.009
-
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1081-2.
Score: 0.009
-
Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1310.
Score: 0.009
-
Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996 Dec 27; 62(12):1709-14.
Score: 0.009
-
Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. Transplantation. 1996 Apr 27; 61(8):1228-33.
Score: 0.008
-
Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts. Transplant Proc. 1996 Apr; 28(2):732.
Score: 0.008
-
Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
Score: 0.008
-
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
Score: 0.008
-
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
Score: 0.008
-
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc. 1995 Feb; 27(1):191-3.
Score: 0.008
-
Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
Score: 0.008
-
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
Score: 0.007
-
Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
Score: 0.007
-
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation. 1993 Mar; 55(3):659-61.
Score: 0.007
-
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):414-5.
Score: 0.007